Cargando…
Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
Epithelial ovarian cancer remains the most lethal female malignancy despite options for systemic therapy and the emergence of targeted therapies. Although initial response to therapy is observed, recurrence and ultimately chemoresistance result in overall therapeutic failure. This pattern has been e...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511803/ https://www.ncbi.nlm.nih.gov/pubmed/36176755 http://dx.doi.org/10.20517/cdr.2021.146 |